Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Japan shares fall as virus surge, firmer yen weigh

Published 11/19/2020, 10:58 AM
Updated 11/19/2020, 11:00 AM
© Reuters.
JP225
-
TOPX
-
4503
-
4568
-
8001
-
8306
-

By Stanley White
TOKYO, Nov 19 (Reuters) - Japanese stocks fell for a second
session on Thursday as rising coronavirus cases at home and
exporters' concerns over a firmer yen dented investor sentiment.
The Nikkei 225 Index .N225 fell 0.48% to 25,603.77 at 0205
GMT, while the broader Topix .TOPX was down 0.25% at 1,716.30.
COVID-19 cases in Tokyo hit a record daily high on Wednesday
and investors are worried that policymakers will order services
sector companies to shorten their business hours. Infections are also rising rapidly in the United States,
raising concerns about the health of the world's largest
economy. "Equity prices have risen very rapidly, so we are now in a
phase where many people are considering taking profits," said
Masayuki Kichikawa, chief macro strategist at Sumitomo Mitsui
Asset Management.
"If this were the spring, the Japanese government would
already be telling people to stay at home. However, the downside
for equities is limited because the decline in economic activity
is likely to be less than it was earlier this year."
The underperformers among the Topix 30 were Astellas Pharma
Inc 4503.T down 2.27%, followed by Mitsubishi UFJ Financial
Group Inc 8306.T losing 1.90%.
Shares also took a hit as the yen JPY=D3 rose to a
one-week high. A stronger yen tends to decrease earnings for
exporters.
The stocks that gained the most among the top 30 core Topix
names were drugmaker Daiichi Sankyo Co Ltd 4568.T , up 2.28%,
followed by trading house Itochu Corp 8001.T , which rose
1.71%.
There were 72 advancers on the Nikkei index against 150
decliners. About 0.47 billion shares traded on the Tokyo Stock
Exchange's main board .TOPX , compared with an average of 1.13
billion in the past 30 days.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.